142 related articles for article (PubMed ID: 799348)
1. Plasma inhibitors of the Hageman factor dependent pathways.
Schreiber AD
Semin Thromb Hemost; 1976 Jul; 3(1):32-51. PubMed ID: 799348
[TBL] [Abstract][Full Text] [Related]
2. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
Weiss AS; Gallin JI; Kaplan AP
J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
[TBL] [Abstract][Full Text] [Related]
3. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
4. The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation.
Kaplan AP; Meier HL; Mandle R
Semin Thromb Hemost; 1976 Jul; 3(1):1-26. PubMed ID: 139682
[No Abstract] [Full Text] [Related]
5. [Factor XII (HAGEMAN FACTOR)].
Kase F; Klír P; Pospísil J; Poucková P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1978; 105(1):1-19. PubMed ID: 77809
[TBL] [Abstract][Full Text] [Related]
6. Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
Travis J; Salvesen G
Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838
[TBL] [Abstract][Full Text] [Related]
7. The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.
Goldsmith GH; Saito H; Ratnoff OS
J Clin Invest; 1978 Jul; 62(1):54-60. PubMed ID: 659637
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation.
Schreiber AD; Kaplan AP; Austen KF
J Clin Invest; 1973 Jun; 52(6):1402-9. PubMed ID: 4703226
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
10. Hageman-factor-dependent coagulation, fibrinolysis, and kinin generation.
Austen KF
Transplant Proc; 1974 Mar; 6(1):39-45. PubMed ID: 4274038
[No Abstract] [Full Text] [Related]
11. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships.
Kaplan AP; Ghebrehiwet B; Silverberg M; Sealey JE
Crit Rev Immunol; 1981 Sep; 3(1):75-93. PubMed ID: 7047077
[TBL] [Abstract][Full Text] [Related]
12. [Plasma kallikrein: new functions].
Paskhina TS
Biokhimiia; 1976 Aug; 41(8):1347-51. PubMed ID: 1030643
[TBL] [Abstract][Full Text] [Related]
13. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
[TBL] [Abstract][Full Text] [Related]
14. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
Joist JH; Cowan JF; Khan M
J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
[TBL] [Abstract][Full Text] [Related]
15. Prorenin-renin conversion by the contact activation system in human plasma: role of plasma protease inhibitors.
Derkx FH; Bouma BN; Schalekamp MA
J Lab Clin Med; 1984 Apr; 103(4):560-73. PubMed ID: 6366096
[TBL] [Abstract][Full Text] [Related]
16. Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen.
Mandle RJ; Kaplan AP
Blood; 1979 Oct; 54(4):850-62. PubMed ID: 89876
[TBL] [Abstract][Full Text] [Related]
17. Hageman complement and factor.
Kim Z
Ann Allergy; 1977 Mar; 38(3):211-4. PubMed ID: 842908
[TBL] [Abstract][Full Text] [Related]
18. Plasma inhibitors of the components of the fibrinolytic pathway in man.
Schreiber AD; Kaplan AP; Austen KF
J Clin Invest; 1973 Jun; 52(6):1394-401. PubMed ID: 4122174
[TBL] [Abstract][Full Text] [Related]
19. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation.
Kaplan AP
Fed Proc; 1983 Nov; 42(14):3123-7. PubMed ID: 6556144
[TBL] [Abstract][Full Text] [Related]
20. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
Erem C
Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
